Tom Kraus, VP of Government Relations for ASHP, discusses what they're focusing on regarding drug pricing legislation.
Aislinn Antrim, Managing Editor
Advertisement
Articles by Aislinn Antrim, Managing Editor
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Reformulated Ranitidine After 5-Year Absence
2
Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes
3
Durvalumab Receives FDA Approval for Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
4
FDA Approves Sibeprenlimab for Patients with IgAN
5
